Abstract
Since a relationship between cigarette smoking and the occurrence of Graves’ ophthalmopathy has been recently postulated, we reviewed the smoking habits of 1730 women, including subjects without thyroid disease, with nontoxic goiter (NTG), toxic nodular goiter or toxic adenoma (TNG), Hashimoto’s thyroiditis (HT), Graves’ disease without ophthalmopathy (GD) or with ophthalmopathy (GO). The prevalence of smokers in NTG, TNG and HT was about 30%, not different from that of controls. Smokers were 47.9% in GD and 64.2% in GO groups. The latter figures were highly different from those of the other groups and also from each other. The percentage of heavy smokers was higher in patients with more severe ophthalmopathy. No clear explanation for this phenomenon can be offered. The absence of a high prevalence of smokers among patients with nontoxic goiter, nonautoimmune hyperthyroidism and Hashimoto’s thyroiditis, limits the impact that smoking might have had in the pathogenesis of goiter, hyperthyroidism and autoimmune phenomena of GD and GO.
This is a preview of subscription content, log in via an institution to check access.
References
Melander A., Nordenskjold E., Lundh B., Thorell J. Influence of smoking on thyroid activity. Acta Med. Scand. 209: 41, 1981.
Cryer P.E., Haymond M.W., Santiago J.V., Shah S.H. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N. Engl. J. Med. 295: 573, 1976.
Christensen S.B., Ericsson U.-B., Janzon L., Tibblin S., Melander A. Influence of cigarette smoking on goiter formation, thyroglobulin, and thyroid hormone levels in women. J. Clin. Endocrinol. Metab. 58: 615, 1984.
Hegedus L., Karstrup S., Veiergang D., Jacobsen B., Skovsted L., Feldt-Rasmussen U. High frequency of goiter in cigarette smokers. Clin. Endocrinol. (Oxf.) 22: 287, 1985.
Melander A., Westgren U., Ericsson L.E., Smedler F. Influence of the sympathetic nervous system on the secretion and metabolism of thyroid hormone. Endocrinology 101: 1228, 1977.
Saito K., Yamamoto K., Takai T., Yoshida S. Inhibition of iodide accumulation by Perchlorate and thiocyanate in a model of the thyroid iodide transport system. Acta Endocrinol. (Copenh.) 104: 456, 1983.
Hagg E., Asplund K. Is endocrine ophthalmopathy related to smoking? Br. Med. J. 295: 634, 1987.
Bartalena L., Marcocci C., Chiovato L., Laddaga M., Lepri G., Andreani D., Cavallacci G., Baschieri L., Pinchera A. Orbital cobalt irradiation combined with systemic corticosteroids for Graves’ ophthalmopathy: comparison with systemic corticosteroids alone. J. Clin. Endocrinol. Metab. 56: 1139, 1983.
Miller L.G., Goldstein G., Murphy M., Ginns L.C. Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest 82: 526, 1982.
Costabel U., Bross K.J., Reuter C., Ruhle K., Matthys H. Alterations in immunoregulatory T-cell subsets in cigarette smokers. A phenotypic analysis of bronchoalveolar and blood lymphocytes. Chest 90: 39, 1986.
Ginns L.C., Ryu J.H., Rogol P.R., Sprince N.L., Oliver L.C., Larsson C.J. Natural killer activity in cigarette smokers and asbestos workers. Am. Rev. Respir. Dis. 131: 831, 1985.
Phillips B., Marshall M.E., Brown S., Thompson J.E. Effect of smoking on human natural killer cell activity. Cancer 56: 2789, 1985.
Jacobson D.H., Gorman C.A. E. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment. Endocr. Rev. 5: 200, 1984.
Marcocci C., Bartalena L., Bogazzi F., Panicucci M., Lepri A., Pinchera A. Studies on the occurrence of ophthalmopathy in Graves’ disease. Acta Endocrinol. (Copenh.) 120: 473, 1989.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bartalena, L., Martino, E., Marcocci, C. et al. More on smoking habits and Graves’ ophthalmopathy. J Endocrinol Invest 12, 733–737 (1989). https://doi.org/10.1007/BF03350047
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350047